Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2?
BTIG analyst Ryan Zimmerman maintains Alcon (NYSE:ALC) with a Buy and raises the price target from $92 to $96.
Morgan Stanley analyst Patrick Wood upgrades Alcon (NYSE:ALC) from Underweight to Equal-Weight and raises the price target f...
Needham analyst David Saxon reiterates Alcon (NYSE:ALC) with a Buy and maintains $101 price target.
Alcon (NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY® Vitreo...
Top performing large-cap stocks in the last week: MSTR, MNDY, ONON, SE, PODD, DELL, VOD, ALC, SMCI, CRBG. Analysts raise price ...
Alcon's recent upgrades and promising opportunities, including the BELKIN Vision acquisition, expanding glaucoma treatment ...
Wells Fargo analyst Larry Biegelsen maintains Alcon (NYSE:ALC) with a Overweight and raises the price target from $89 to $94.
Oppenheimer analyst Steven Lichtman upgrades Alcon (NYSE:ALC) from Perform to Outperform and announces $103 price target.
